 WALTHAM, Mass., Sept. 06, 2022 GLOBE NEWSWIRE -- Adagio Therapeutics, Inc. Nasdaq: ADGI, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of differentiated products for the prevention and treatment of infectious diseases, today announced participation in the following upcoming investor conferences: 